Search results
Results From The WOW.Com Content Network
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States , Puerto Rico , Mexico , and Brazil . [ 3 ] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Website. www .sunquestinfo .com. Sunquest Information Systems Inc. is a U.S. developer of medical laboratory and diagnostic software. It was founded in 1979 and as of 2012, is a subsidiary of Roper Technologies. [ 1] Sunquest software includes clinical diagnostic data management, blood bank data management, molecular diagnostics analysis and ...
Website. www.quest.com. Quest Software, also known as Quest, is a privately held software company headquartered in Aliso Viejo, California, United States. Quest provides cloud management, software as a service, security, workforce mobility, and backup & recovery. The company was founded in 1987 and has 53 offices in 24 countries.
x. AOL works best with the latest versions of the browsers. You're using an outdated or unsupported browser and some AOL features may not work properly.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
554 [ 1] Parent. Quest Diagnostics. Website. www .celera .com. Celera Corporation is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera, spun off into an independent company in 2008, and finally acquired by Quest Diagnostics in 2011. [ 2]
Paid CEOs an average of. $5,080,766. in the last year of her directorship, more than 10% of all directors. Increased CEO pay by an average of. $3,395,443. between 2008 and 2012, more than 69% of all directors. Shares of her companies decreased by. 69.1%. between 2008 and 2012, better performance than 1% of all directors.